Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 24618753)

1.

Use of sealed grafts in the HeartMate II left ventricular assist device inflow and outflow conduits.

Gregoric ID, Radovancevic R, Patel M, Fenik Y, Cohn WE, Frazier OH.

ASAIO J. 2014 May-Jun;60(3):300-3. doi: 10.1097/MAT.0000000000000071.

PMID:
24618753
2.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
3.

Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.

Slaughter MS, Naka Y, John R, Boyle A, Conte JV, Russell SD, Aaronson KD, Sundareswaran KS, Farrar DJ, Pagani FD.

J Heart Lung Transplant. 2010 Jun;29(6):616-24. doi: 10.1016/j.healun.2010.02.003. Epub 2010 Apr 18.

PMID:
20400335
4.

Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.

John R, Naka Y, Park SJ, Sai-Sudhakar C, Salerno C, Sundareswaran KS, Farrar DJ, Milano CA.

J Thorac Cardiovasc Surg. 2014 Feb;147(2):581-9; discussion 589. doi: 10.1016/j.jtcvs.2013.10.024.

PMID:
24418362
5.

Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.

Boyle AJ, Jorde UP, Sun B, Park SJ, Milano CA, Frazier OH, Sundareswaran KS, Farrar DJ, Russell SD; HeartMate II Clinical Investigators.

J Am Coll Cardiol. 2014 Mar 11;63(9):880-8. doi: 10.1016/j.jacc.2013.08.1656. Epub 2013 Dec 11.

6.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

PMID:
20447659
7.

The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.

Donneyong M, Cheng A, Trivedi JR, Schumer E, McCants KC, Birks EJ, Slaughter MS.

ASAIO J. 2014 May-Jun;60(3):294-9. doi: 10.1097/MAT.0000000000000065.

PMID:
24614355
8.

Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.

Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D.

J Am Coll Cardiol. 2010 Oct 5;56(15):1207-13. doi: 10.1016/j.jacc.2010.05.016. Epub 2010 Jul 2.

9.

Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.

Salerno CT, Sundareswaran KS, Schleeter TP, Moanie SL, Farrar DJ, Walsh MN.

J Heart Lung Transplant. 2014 Aug;33(8):809-15. doi: 10.1016/j.healun.2014.02.024. Epub 2014 Feb 26.

PMID:
24735680
10.

Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.

Uriel N, Han J, Morrison KA, Nahumi N, Yuzefpolskaya M, Garan AR, Duong J, Colombo PC, Takayama H, Thomas S, Naka Y, Jorde UP.

J Heart Lung Transplant. 2014 Jan;33(1):51-9. doi: 10.1016/j.healun.2013.10.005. Epub 2013 Nov 28.

PMID:
24290832
11.

The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device.

Siegenthaler MP, Martin J, Pernice K, Doenst T, Sorg S, Trummer G, Friesewinkel O, Beyersdorf F.

Eur J Cardiothorac Surg. 2003 May;23(5):748-54; discussion 754-5.

PMID:
12754028
12.

Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors.

Morgan JA, Brewer RJ, Nemeh HW, Gerlach B, Lanfear DE, Williams CT, Paone G.

ASAIO J. 2014 May-Jun;60(3):284-9. doi: 10.1097/MAT.0000000000000074.

PMID:
24625532
13.

Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.

Gregoric ID, Bruckner BA, Jacob L, Kar B, Cohn WE, La Francesca S, Frazier OH.

Ann Thorac Surg. 2008 May;85(5):1646-9. doi: 10.1016/j.athoracsur.2008.01.020.

PMID:
18442556
14.

Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.

Fine NM, Topilsky Y, Oh JK, Hasin T, Kushwaha SS, Daly RC, Joyce LD, Stulak JM, Pereira NL, Boilson BA, Clavell AL, Edwards BS, Park SJ.

JACC Cardiovasc Imaging. 2013 Nov;6(11):1129-40. doi: 10.1016/j.jcmg.2013.06.006. Epub 2013 Oct 2.

15.

Recent improvements in outcome with the Novacor left ventricular assist device.

Strauch JT, Spielvogel D, Haldenwang PL, Correa RK, deAsla RA, Seissler PE, Baran DA, Gass AL, Lansman SL.

J Heart Lung Transplant. 2003 Jun;22(6):674-80.

PMID:
12821164
16.
17.

The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.

18.

Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.

Goda M, Jacobs S, Rega F, Peerlinck K, Jacquemin M, Droogne W, Vanhaecke J, Van Cleemput J, Van den Bossche K, Meyns B.

J Heart Lung Transplant. 2013 May;32(5):539-45. doi: 10.1016/j.healun.2013.02.006.

PMID:
23570742
19.

Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.

Sandner SE, Riebandt J, Haberl T, Mahr S, Rajek A, Schima H, Wieselthaler GM, Laufer G, Zimpfer D.

J Heart Lung Transplant. 2014 Jan;33(1):88-93. doi: 10.1016/j.healun.2013.10.009. Epub 2013 Oct 11.

PMID:
24239003
20.

Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.

Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, Acker MA, Goldstein DL, Silvestry SC, Milano CA, Timothy Baldwin J, Pinney S, Eduardo Rame J, Miller MA.

J Heart Lung Transplant. 2014 Jan;33(1):12-22. doi: 10.1016/j.healun.2013.11.001. Epub 2013 Nov 27.

PMID:
24418730
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk